citadel

Ken Griffin, founder and CEO of Citadel, said artificial intelligence is rapidly transforming high-level financial research, warning that tasks once requiring teams of PhD-level professionals are now being completed by AI in a matter of days rather than months. AI Reshaping Elite Finance Work...

Circle Internet Group, Inc (NYSE:CRCL) stock may suddenly be giving traders and crypto investors something they have not seen in months: a technical breakout setup backed by accelerating network activity. Chart created using Benzinga Pro CRCL stock has surged more than 36% over the past year and...

The week brought a mix of stories, from Trump’s strategy against China to the U.S. economy’s resilience amid the Iran war. Here’s a quick recap of the key events that unfolded over the week. Trump’s Stealth Weapon Against China For over a decade, China has been subtly...

Ken Griffin is reportedly pushing back hard after New York City Mayor Zohran Mamdani used the Citadel CEO’s $238 million Manhattan penthouse as a prop in a ‘tax-the-rich' campaign video. In a Thursday email reviewed by The Wall Street Journal, Citadel COO Gerald Beeson warned the firm may not...

Hedge funds don't need headlines to move — they need inflection points. ImmunityBio Inc (NASDAQ:IBRX) just delivered one. ImmunityBio stock has gone vertical, up nearly 96% year-to-date, but the real story isn't the stock move. It's the number behind it. Track IBRX stock here. On Thursday,...

BitMine Immersion Technologies Inc (AMEX:BMNR) just dropped the kind of earnings update that makes you double-check the ticker. The company behind one of the most bizarrely explosive stock charts of 2025 — up nearly 280% year-to-date even after a brutal 49% pullback this month — used its latest...

DraftKings Inc (NASDAQ:DKNG) just hit a Death Cross — and its billionaire backers are feeling the chill. DraftKings stock has tumbled nearly 20% in a month, just as the sports-betting giant prepares to report its third-quarter earnings on Thursday after the close. For investors like Ken Griffin...

Pfizer Inc's (NYSE:PFE) lawsuit. Novo Nordisk A/S' (NYSE:NVO) counterbid. And in the middle of it all — a quiet $45 million position that might turn into Andreas Halvorsen's next masterstroke. After years of fighting from the sidelines of the Ozempic boom, Pfizer is finally throwing punches....

Paul Tudor Jones and Ken Griffin just turned a bold quantum bet into a windfall. Rigetti Computing Inc (NASDAQ: RGTI), a small-cap quantum computing company, has surged 162.9% since June 30, delivering huge gains for the billionaire investors who got in early. Track RGTI stock here. Paul Tudor...

In a trend mirroring that of Hollywood celebrities and professional athletes, top hedge fund recruits are now seeking representation from talent agents. Hedge funds, particularly the giant multimanager platforms, are sitting on record levels of capital. These firms allocate tens of billions across...

Citadel LLC founder Ken Griffin says the quickest way to know whether you're in the right job is to ask if you still crack open the textbooks. What Happened: "Stay current in the body of knowledge that represents the career you've chosen," he told S&P Global's Leaders podcast, released this...

Citadel LLC. founder Ken Griffin told the hedge fund's 300 incoming summer interns that investors who "go on defense" during market turmoil almost always lose money, and he advised them to park cash rather than crowd into so-called safe trades. What Happened: "In finance, when you're playing...

Citadel CEO Ken Griffin is donating $15 million and lending his rare first editions of the U.S. Constitution and Bill of Rights to Philadelphia’s National Constitution Center ahead of America’s 250th anniversary celebration. What Happened: The hedge fund billionaire’s gift...

Ken Griffin, founder of Citadel hedge fund, has expressed concern over the swift contraction of the market and the deterioration of the U.S.’s global financial standing, attributing these issues to the ongoing trade war. What Happened: Griffin, who is at the helm of the $65 billion hedge fund...

Ken Griffin's hedge fund Citadel has placed a £305 million ($390 million) short bet against GSK PLC (NYSE:GSK), marking the largest wager against the UK pharma giant in over a decade, reported the Financial Times. The position, disclosed to the UK's Financial Conduct Authority, amounts to 0.51% of...